Search
Close this search box.
Logo Asphalion

Course | Regulatory aspects of vaccine development

TRANSVAC2 supported innovation for both prophylactic and therapeutic vaccine development by providing high-quality technical services across four different service platforms: Technology (for process development and GMP production), Immunocorrelates & Systems Biology, Animal models, and support for Clinical Trials. TRANSVAC also offered training courses to provide fundamental and advanced knowledge on a wide-range of vaccine development-related topics.

TRANSVAC2 supported innovation for both prophylactic and therapeutic vaccine development by providing high-quality technical services across four different service platforms: Technology (for process development and GMP production), Immunocorrelates & Systems Biology, Animal models, and support for Clinical Trials. TRANSVAC also offered training courses to provide fundamental and advanced knowledge on a wide-range of vaccine development-related topics.
September 7, 2023

Enrol for free in this online course developed within the Horizon 2020 funded project TRANSVAC2, designed for professionals working on vaccine development who are in need of an introduction to the regulatory issues associated with the field.

The course is self-paced, consisting of ca. 10 hours of lectures, divided into prophylactic vaccines including CMC, preclinical and Phase I-II of vaccine development and into therapeutic and cancer vaccines, covering both the scientific and regulatory point of view.

Asphalion expert Chris Mann is in charge of the following lectures:

  • Regulatory landscape for preclinical testing
  • Clinical vaccine development
  • Cancer vaccines and ATMPs.

 

Sign up to the course for free here: https://bit.ly/44HpZAH

For any further enquiries or needs, you can contact us at: [email protected]

Search News & Events

  • Filter by category

Share

Related news and events

Clinical Trial Support in the EU

For companies engaged in clinical development programs for pharmaceutical products, robust regulatory support is essential for obtaining trial approval and initiation, as well as maintaining

FORCE REPAIR | 3rd Progress Meeting

Last week, the Force Repair project partners met in Pavia, Italy, for the the 3rd progress meeting. ASPHALION expert Jon Giblin attended the meeting, providing

RBDCOV | Project extension

The European Commission has granted a fifteen-month extension to the EU-funded RBDCOV project, extending the journey to August 31, 2025. This extra time is crucial

For further information

If you are interested in our services, or wish to get in touch for a general enquiry, please contact us for more information.

Fill the form and we will contact you as soon as possible.

You can also follow us on:

Schedule a Free Meeting

Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts. 

We will be happy to assist you!

Schedule a meeting